These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37941863)

  • 1. Comparison of Risk Factors During First and Second Wave of COVID-19 in Patients with Autoimmune Rheumatic Diseases (AIRD): Results from KRACC Subset.
    Jain V; Shobha V; Kumar S; Janardana R; Selvam S
    Mediterr J Rheumatol; 2023 Sep; 34(3):342-348. PubMed ID: 37941863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence and outcome of COVID-19 in AIRD patients on concomitant treatment with Tofacitinib- results from KRA COVID COHORT (KRACC) subset.
    Chebbi P; Shobha V; Rao VK; Haridas V; Janardana R; Pinto B; Kumar S; Patil A; Tekkatte R; Salanke M; Mahendranath KM
    BMC Rheumatol; 2023 Jul; 7(1):22. PubMed ID: 37496101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective longitudinal study evaluating the influence of immunosuppressives and other factors on COVID-19 in autoimmune rheumatic diseases.
    Patil A; Chanakya K; Shenoy P; Chandrashekara S; Haridas V; Kumar S; Daware M; Janardana R; Pinto B; Subramanian R; Nagaraj S; Singh YP; Singhai S; Jois R; Jain V; Srinivasa C; Dharmanand BG; Dharmapalaiah C; Sangeetha KN; Rao VK; Shobha V
    BMC Rheumatol; 2022 Jun; 6(1):32. PubMed ID: 35698182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 infection and efficacy of vaccination in patients with rheumatic diseases during Omicron outbreak in South Korea: a prospective cohort study.
    Kim YK; Kim JY; Jung JI; Park JK; Lee EY; Lee EB; Park JW
    RMD Open; 2023 Nov; 9(4):. PubMed ID: 37973535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody responses after documented COVID-19 disease in patients with autoimmune rheumatic disease.
    Shenoy P; Ahmed S; Shanoj KC; Shenoy V; Damodaran D; Menon AR; Alias B; SanjoSaijan ; Devakumar D; Babu ASS
    Clin Rheumatol; 2021 Nov; 40(11):4665-4670. PubMed ID: 34155573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CovAID: Identification of factors associated with severe COVID-19 in patients with inflammatory rheumatism or autoimmune diseases.
    Chevalier K; Genin M; Jean TP; Avouac J; Flipo RM; Georgin-Lavialle S; El Mahou S; Pertuiset E; Pham T; Servettaz A; Marotte H; Domont F; Chazerain P; Devaux M; Mekinian A; Sellam J; Fautrel B; Rouzaud D; Ebstein E; Costedoat-Chalumeau N; Richez C; Hachulla E; Mariette X; Seror R
    Front Med (Lausanne); 2023; 10():1152587. PubMed ID: 37035330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 Igg seroprevalence in IBD patients treated with biologics: first vs. second pandemic wave in a prospective study.
    Mossa M; Neri B; Montesano L; Salvatori S; Marafini I; Scucchi L; Lolli E; Massoud R; Petruzziello C; Bernardini S; Calabrese E; Monteleone G; Biancone L
    Eur Rev Med Pharmacol Sci; 2022 May; 26(10):3787-3796. PubMed ID: 35647861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 outcomes in patients with and without autoimmune rheumatic diseases: A multicenter comparative study.
    Abdulnaby NK; Gamal SM; Alkemary A; Abdo M; Sabry IM; Belita MI; Mohamed SS
    Int J Rheum Dis; 2023 May; 26(5):870-877. PubMed ID: 36929695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing India's Second COVID Wave with the First Wave-A Single-Center Experience.
    Kapoor M; Singh BO; Panda PK; Dhanger P; Kataria A
    Recent Adv Antiinfect Drug Discov; 2022; 17(3):178-186. PubMed ID: 35770393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of COVID-19 in patients with autoimmune rheumatic diseases.
    Pang R; Zhao J; Gan Z; Hu Z; Xue X; Wu Y; Qiao Q; Zhong A; Xia X; Liao H; Wang Z; Zhang L
    Aging (Albany NY); 2020 Dec; 12(23):23427-23435. PubMed ID: 33289698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is vaccination against COVID-19 associated with autoimmune rheumatic disease flare? A self-controlled case series analysis.
    Nakafero G; Grainge MJ; Card T; Mallen CD; Nguyen Van-Tam JS; Williams HC; Abhishek A
    Rheumatology (Oxford); 2023 Apr; 62(4):1445-1450. PubMed ID: 36048896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased 30-day and 1-year mortality rates and lower coronary revascularisation rates following acute myocardial infarction in patients with autoimmune rheumatic disease.
    Van Doornum S; Bohensky M; Tacey MA; Brand CA; Sundararajan V; Wicks IP
    Arthritis Res Ther; 2015 Feb; 17(1):38. PubMed ID: 25879786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Autoimmune Inflammatory Rheumatic Outcomes of COVID-19 : A Binational Cohort Study.
    Kim MS; Lee H; Lee SW; Kwon R; Rhee SY; Lee JA; Koyanagi A; Smith L; Fond G; Boyer L; Lee J; Rahmati M; Shin JY; Min C; Shin JI; Yon DK
    Ann Intern Med; 2024 Mar; 177(3):291-302. PubMed ID: 38437702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between first and second wave of COVID-19 outbreak in older people: the COPE multicentre European observational cohort study.
    Verduri A; Short R; Carter B; Braude P; Vilches-Moraga A; Quinn TJ; Collins J; Lumsden J; McCarthy K; Evans L; Myint PK; Hewitt J;
    Eur J Public Health; 2022 Oct; 32(5):807-812. PubMed ID: 35997587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of COVID-19 Pandemic on Patients With Rheumatic Diseases in Medina, Saudi Arabia: An Observational Cross-Sectional Study.
    Safar Alsofyani I; Samman BS; Alhubayshi SS; Ellahi AT; Alsaedi AB; Almansour M
    Cureus; 2024 May; 16(5):e60128. PubMed ID: 38864060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 susceptibility and clinical outcomes in autoimmune inflammatory rheumatic diseases (AIRDs): a systematic review and meta-analysis.
    Shin JI; Kim SE; Lee MH; Kim MS; Lee SW; Park S; Shin YH; Yang JW; Song JM; Moon SY; Kim SY; Park Y; Suh DI; Yang JM; Cho SH; Jin HY; Hong SH; Won HH; Kronbichler A; Koyanagi A; Jacob L; Hwang J; Tizaoui K; Lee KH; Kim JH; Yon DK; Smith L
    Eur Rev Med Pharmacol Sci; 2022 May; 26(10):3760-3770. PubMed ID: 35647859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases.
    Freites Nuñez DD; Leon L; Mucientes A; Rodriguez-Rodriguez L; Font Urgelles J; Madrid García A; Colomer JI; Jover JA; Fernandez-Gutierrez B; Abasolo L
    Ann Rheum Dis; 2020 Nov; 79(11):1393-1399. PubMed ID: 32769150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease.
    Frommert LM; Arumahandi de Silva AN; Zernicke J; Scholz V; Braun T; Jeworowski LM; Schwarz T; Tober-Lau P; Ten Hagen A; Habermann E; Kurth F; Sander LE; Corman VM; Burmester GR; Biesen R; Albach FN; Klotsche J
    RMD Open; 2022 Dec; 8(2):. PubMed ID: 36597977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison between the first and second COVID-19 wave of patients who required invasive mechanical ventilation in an intensive care unit in Argentina].
    Musso G; Gonzalez C; Gomez MC; Appendino G; Clemente L; Abarca A; Friscione L; Plotnikow GA; Montagner F; Abbondanzieri O; Id Betan L; Braconi F; Bianco A; Guerrero P; Garrido Y; Carranza H; Berloni L; Lovesio C; Managó M
    Medicina (B Aires); 2022; 82(4):487-495. PubMed ID: 35904903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 vaccine hesitancy in patients with systemic autoimmune rheumatic disease: an interview-based survey.
    Gaur P; Agrawat H; Shukla A
    Rheumatol Int; 2021 Sep; 41(9):1601-1605. PubMed ID: 34213580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.